Cargando…

Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study

The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German...

Descripción completa

Detalles Bibliográficos
Autores principales: Huth, Cornelia, von Toerne, Christine, Schederecker, Florian, de las Heras Gala, Tonia, Herder, Christian, Kronenberg, Florian, Meisinger, Christa, Rathmann, Wolfgang, Koenig, Wolfgang, Waldenberger, Melanie, Roden, Michael, Peters, Annette, Hauck, Stefanie M., Thorand, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451724/
https://www.ncbi.nlm.nih.gov/pubmed/30599058
http://dx.doi.org/10.1007/s10654-018-0475-8
_version_ 1783409204791345152
author Huth, Cornelia
von Toerne, Christine
Schederecker, Florian
de las Heras Gala, Tonia
Herder, Christian
Kronenberg, Florian
Meisinger, Christa
Rathmann, Wolfgang
Koenig, Wolfgang
Waldenberger, Melanie
Roden, Michael
Peters, Annette
Hauck, Stefanie M.
Thorand, Barbara
author_facet Huth, Cornelia
von Toerne, Christine
Schederecker, Florian
de las Heras Gala, Tonia
Herder, Christian
Kronenberg, Florian
Meisinger, Christa
Rathmann, Wolfgang
Koenig, Wolfgang
Waldenberger, Melanie
Roden, Michael
Peters, Annette
Hauck, Stefanie M.
Thorand, Barbara
author_sort Huth, Cornelia
collection PubMed
description The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German KORA F4/FF4 study (6.5-year follow-up). 892 participants aged 42–81 years were selected using a case-cohort design, including 123 persons with incident type 2 diabetes and 255 persons with incident WHO-defined prediabetes. Prospective associations between protein levels and diabetes, prediabetes as well as continuous fasting and 2 h glucose, fasting insulin and insulin resistance were investigated using regression models adjusted for established risk factors. The best predictive panel of proteins on top of a non-invasive risk factor model or on top of HbA1c, age, and sex was selected. Mannan-binding lectin serine peptidase (MASP) levels were positively associated with both incident type 2 diabetes and prediabetes. Adiponectin was inversely associated with incident type 2 diabetes. MASP, adiponectin, apolipoprotein A-IV, apolipoprotein C-II, C-reactive protein, and glycosylphosphatidylinositol specific phospholipase D1 were associated with individual continuous outcomes. The combination of MASP, apolipoprotein E (apoE) and adiponectin improved diabetes prediction on top of both reference models, while prediabetes prediction was improved by MASP plus CRP on top of the HbA1c model. In conclusion, our mass spectrometric approach revealed a novel association of MASP with incident type 2 diabetes and incident prediabetes. In combination, MASP, adiponectin and apoE improved type 2 diabetes prediction beyond non-invasive risk factors or HbA1c, age and sex. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10654-018-0475-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6451724
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-64517242019-04-17 Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study Huth, Cornelia von Toerne, Christine Schederecker, Florian de las Heras Gala, Tonia Herder, Christian Kronenberg, Florian Meisinger, Christa Rathmann, Wolfgang Koenig, Wolfgang Waldenberger, Melanie Roden, Michael Peters, Annette Hauck, Stefanie M. Thorand, Barbara Eur J Epidemiol Diabetes Mellitus The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German KORA F4/FF4 study (6.5-year follow-up). 892 participants aged 42–81 years were selected using a case-cohort design, including 123 persons with incident type 2 diabetes and 255 persons with incident WHO-defined prediabetes. Prospective associations between protein levels and diabetes, prediabetes as well as continuous fasting and 2 h glucose, fasting insulin and insulin resistance were investigated using regression models adjusted for established risk factors. The best predictive panel of proteins on top of a non-invasive risk factor model or on top of HbA1c, age, and sex was selected. Mannan-binding lectin serine peptidase (MASP) levels were positively associated with both incident type 2 diabetes and prediabetes. Adiponectin was inversely associated with incident type 2 diabetes. MASP, adiponectin, apolipoprotein A-IV, apolipoprotein C-II, C-reactive protein, and glycosylphosphatidylinositol specific phospholipase D1 were associated with individual continuous outcomes. The combination of MASP, apolipoprotein E (apoE) and adiponectin improved diabetes prediction on top of both reference models, while prediabetes prediction was improved by MASP plus CRP on top of the HbA1c model. In conclusion, our mass spectrometric approach revealed a novel association of MASP with incident type 2 diabetes and incident prediabetes. In combination, MASP, adiponectin and apoE improved type 2 diabetes prediction beyond non-invasive risk factors or HbA1c, age and sex. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10654-018-0475-8) contains supplementary material, which is available to authorized users. Springer Netherlands 2018-12-31 2019 /pmc/articles/PMC6451724/ /pubmed/30599058 http://dx.doi.org/10.1007/s10654-018-0475-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Diabetes Mellitus
Huth, Cornelia
von Toerne, Christine
Schederecker, Florian
de las Heras Gala, Tonia
Herder, Christian
Kronenberg, Florian
Meisinger, Christa
Rathmann, Wolfgang
Koenig, Wolfgang
Waldenberger, Melanie
Roden, Michael
Peters, Annette
Hauck, Stefanie M.
Thorand, Barbara
Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
title Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
title_full Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
title_fullStr Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
title_full_unstemmed Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
title_short Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
title_sort protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the kora f4/ff4 study
topic Diabetes Mellitus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451724/
https://www.ncbi.nlm.nih.gov/pubmed/30599058
http://dx.doi.org/10.1007/s10654-018-0475-8
work_keys_str_mv AT huthcornelia proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT vontoernechristine proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT schedereckerflorian proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT delasherasgalatonia proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT herderchristian proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT kronenbergflorian proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT meisingerchrista proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT rathmannwolfgang proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT koenigwolfgang proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT waldenbergermelanie proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT rodenmichael proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT petersannette proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT hauckstefaniem proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study
AT thorandbarbara proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study